Merck Buys Out Banyu; Will Bring “Global Perspective” To Japanese R&D
Executive Summary
Merck's acquisition of Banyu will bring "global perspective" to Banyu's R & D efforts, Merck President-Human Health David Anstice said during a Jan. 9 conference call
You may also be interested in...
Merck Drops Strict “No Merger” Policy, But Still Prefers Licensing Deals
Merck appears to be distancing itself from a blanket "no merger" policy by offering a formula under which it would consider a large-scale transaction
Merck Drops Strict “No Merger” Policy, But Still Prefers Licensing Deals
Merck appears to be distancing itself from a blanket "no merger" policy by offering a formula under which it would consider a large-scale transaction
Merck Won’t Go Hollywood: In-House R&D Still Focus As Outside Deals Expand
Merck is on a pace to sign 50 outside R&D alliances during 2003